 |
 Video: What is a Stock Split?
|
|
|
| Zynex, through its subsidiary, Zynex Medical, Inc., designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. Co.'s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation. Co.'s primary product is the NexWave device. According to our ZYXI split history records, Zynex has had 1 split. | |
|
Zynex (ZYXI) has 1 split in our ZYXI split history database. The split for ZYXI took place on January 05, 2022. This was a 11 for 10 split, meaning for each 10 shares of ZYXI owned pre-split, the shareholder now owned 11 shares. For example, a 1000 share position pre-split, became a 1100 share position following the split.
When a company such as Zynex splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the ZYXI split history from start to finish, an original position size of 1000 shares would have turned into 1100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zynex shares, starting with a $10,000 purchase of ZYXI, presented on a split-history-adjusted basis factoring in the complete ZYXI split history.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
04/29/2014 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$0.40 |
|
| End price/share: |
$10.94 |
|
| Starting shares: |
25,000.00 |
|
| Ending shares: |
36,895.67 |
|
| Dividends reinvested/share: |
$0.30 |
|
| Total return: |
3,936.39% |
|
| Average Annual Total Return: |
44.76% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$403,687.79 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/29/2014 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$0.40 |
|
| End price/share: |
$10.94 |
|
| Dividends collected/share: |
$0.30 |
|
| Total return: |
2,710.00% |
|
| Average Annual Total Return: |
39.61% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$281,040.07 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 01/05/2022 | 11 for 10 |
|
|
Free ZYXI Email Alerts:
